Background While increasing coverage of effective vaccines against coronavirus disease
2019 (COVID-19), emergent variants raise concerns about breakthrough infection. Data are …

Objectives To examine the differences in durability and its determinants of humoral immunity
following 2- and 3-dose COVID-19 vaccination. Methods Throughout the pandemic, we …

Background Longitudinal data are lacking to compare booster effects of Delta breakthrough
infection versus third vaccine dose on neutralizing antibodies (NAb) against Omicron. …

Objectives To investigate the role of immunogenicity after the third vaccine dose against
Omicron infection and COVID-19-compatible symptoms of infection. Methods First, we examined …

Background Data are limited on the role of preinfection humoral immunity protection against
Omicron BA.5 infection and long coronavirus disease (COVID) development. Methods We …

To describe the trend of cumulative incidence of coronavirus disease 19 (COVID-19) and
undiagnosed cases over the pandemic through the emergence of severe acute respiratory …

We have performed intra-hospital syndromic surveillance to rapidly detect nosocomial acute
respiratory infection outbreaks in both inpatients and health care workers in a hospital. …

Fig. 1. Setting of the restaurant.(A) Floor plan;(B) image obtained from the video camera. out
both close contact and fomite routes. In this specific context, we found that close contact …

Immunocompromised coronavirus disease 2019 patients are at a higher risk of prolonged
viral shedding than immunocompetent patients. However, as of August 2023, there is no clear …

Background The role of nucleocapsid (N) antibodies and their combination with spike (S)
antibodies against SARS-CoV-2 reinfection remains unclear. We aimed to examine the …